{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:09:28Z","timestamp":1747206568468,"version":"3.40.5"},"reference-count":38,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s479770","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T10:50:11Z","timestamp":1732531811000},"page":"3457-3471","source":"Crossref","is-referenced-by-count":0,"title":["An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients"],"prefix":"10.2147","volume":"Volume 18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9441-9141","authenticated-orcid":true,"given":"Nobuhiro","family":"Goi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumino","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-7809","authenticated-orcid":true,"given":"Shingo","family":"Higa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichiro","family":"Chikama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng0498-319","volume":"18","author":"Town","year":"1998","journal-title":"Nat Genet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00467-012-2242-5","volume":"28","author":"Nesterova","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1086\/302118","volume":"63","author":"Shotelersuk","year":"1998","journal-title":"Am J Hum Genet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/ejhg.2013.204","volume":"22","author":"Levtchenko","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1086\/302509","volume":"65","author":"Forestier","year":"1999","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13256-022-03379-7","volume":"16","author":"Yarahmadi","year":"2022","journal-title":"J Med Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13023-016-0426-y","volume":"11","author":"Elmonem","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/8904_2013_288","volume":"14","author":"Soliman","year":"2014","journal-title":"JIMD Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12882-017-0721-4","volume":"18","author":"Higashi","year":"2017","journal-title":"BMC Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMra020552","volume":"347","author":"Gahl","year":"2002","journal-title":"N Engl J Med"},{"volume-title":"GeneReviews\u00ae [Internet]","year":"1993-2023","key":"ref11"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40123-018-0146-6","volume":"7","author":"Biswas","year":"2018","journal-title":"Ophthalmol Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.2147\/OPTH.S36626","volume":"8","author":"Shams","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/mgme.2000.3062","volume":"71","author":"Gahl","year":"2000","journal-title":"Mol Genet Metab"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/13816818709028529","volume":"8","author":"Dufier","year":"1987","journal-title":"Ophthalmic Paediatr Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s10792-018-0954-7","volume":"39","author":"Flockerzi","year":"2019","journal-title":"Int Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1007\/s00431-003-1349-x","volume":"162","author":"Gahl","year":"2003","journal-title":"Eur J Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1586\/17469899.2013.814885","volume":"8","author":"Huynh","year":"2013","journal-title":"Expert Rev Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/OPTH.S133516","volume":"12","author":"Makuloluwa","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/bjo.87.1.28","volume":"87","author":"Tsilou","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM198703263161304","volume":"316","author":"Kaiser-Kupfer","year":"1987","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/archopht.1990.01070070075038","volume":"108","author":"Kaiser-Kupfer","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ijpharm.2016.10.044","volume":"515","author":"McKenzie","year":"2016","journal-title":"Int J Pharm"},{"key":"ref24","unstructured":"European Medicines Agency. Cystadrops. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cystadrops#authorisation-details. Accessed November 6, 2024."},{"key":"ref25","unstructured":"PR Newswire. U.S. FDA Approves CYSTADROPS\u00ae (Cysteamine Ophthalmic Solution) 0.37%, A New Practical Treatment Option for the Ocular Manifestations of Cystinosis. Available from: https:\/\/www.prnewswire.com\/news-releases\/us-fda-approves-cystadrops-cysteamine-ophthalmic-solution-0-37-a-new-practical-treatment-option-for-The-ocular-manifestations-of-cystinosis-301118026.html. Accessed July 31, 2023."},{"key":"ref26","unstructured":"Pharmaceuticals and Medical Devices Agency. List of Approved Products. Available from: https:\/\/www.pmda.go.jp\/english\/review-services\/reviews\/approved-information\/drugs\/0002.html. Accessed Nov 11, 2024."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40123-017-0089-3","volume":"6","author":"Pinxten","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ymgme.2013.12.298","volume":"111","author":"Labb\u00e9","year":"2014","journal-title":"Mol Genet Metab"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1167\/iovs.16-21080","volume":"58","author":"Liang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref30","unstructured":"Pharmaceuticals and Medical Devices Agency. List of Approved Products \u2013 FY 2014. Available from: https:\/\/www.pmda.go.jp\/files\/000267885.pdf. Accessed June 20, 2024."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/diagnostics10110911","volume":"10","author":"Kowalczyk","year":"2020","journal-title":"Diagnostics"},{"volume-title":"Ophthalmology Clinical Qualification 30 \u201cDevelopment, Anatomy and Function of the Eye\u201d","year":"2016","key":"ref32"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/ijo.IJO_736_18","volume":"67","author":"Ozdemir","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12886-020-01336-w","volume":"20","author":"Csorba","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/eye.1991.139","volume":"5","author":"Bradbury","year":"1991","journal-title":"Eye (Lond)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/mgme.1998.2725","volume":"64","author":"Iwata","year":"1998","journal-title":"Mol Genet Metab"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/bjophthalmol-2020-316450","volume":"105","author":"Liang","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(08)60876-4","volume":"371","author":"Buckley","year":"2008","journal-title":"Lancet"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/97675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/97675","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T10:50:15Z","timestamp":1732531815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/an-open-label-phase-iii-study-to-assess-the-efficacy-and-safety-of-cys-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":38,"URL":"https:\/\/doi.org\/10.2147\/opth.s479770","relation":{},"ISSN":["1177-5483"],"issn-type":[{"type":"electronic","value":"1177-5483"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}